About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Registers
Fees
Vigilance
Safety Watch Reporting
Safety Watch Information
Safety Watch Stay Informed
Key Technical Terms
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact
About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Registers
Fees
Vigilance
Safety Watch Reporting
Safety Watch Information
Safety Watch Stay Informed
Key Technical Terms
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact
Projects
ZAMRA
Projects
Medical Product Advisory : FALSIFIED OZEMPIC® IN CIRCULATION
Medical Product Advisory : FALSIFIED OZEMPIC® IN CIRCULATION
November 9, 2023
Print
Projects
Advisory_Falsified Ozempic_07112023
Download
ALERTS AND PRODUCT RECALLS
View Detail
MEDICAL PRODUCT ALERT NO. 1/2025: FALSIFIED (CONTAMINATED) OXYCONTIN 80MG TABLETS IDENTIFIED IN THE WHO EUROPEAN REGION
Finalised_WHO Alert No 1_Falsified Oxycontin Tablets_19032025Download
Medical Product Alert
View Detail
MEDICAL PRODUCT ALERT: RECALL OF METHYLATED SPIRIT
ZAMRA ALERT_Recall_Methylated Spirit_25112024Download
Medical Product Alert
Home
About Us
e-services
Guidelines
Registers
Newsroom
Fees
Forms
Contact
Search for:
About Us
Overview
Functions
Legislation
Management
The Board
e-services
Guidelines
Registers
Fees
Vigilance
Safety Watch Reporting
Safety Watch Information
Safety Watch Stay Informed
Key Technical Terms
Media Centre
News
Press Releases
Careers
Publications
Tenders
Contact